Cover Image

A STUDY ON CLINICAL SIGNIFICANCE OF MORAXELLA CATARRHALIS IN CAUSING LOWER RESPIRATORY TRACT INFECTIONS IN ADULTS AND THEIR ANTIMICROBIAL USCEPTIBILITY PATTERN IN A TERTIARY CARE HOSPITAL

GOMATHIMANJU B

Abstract


Background of the study - Moraxella catarrhalis ,has now emerged as a pathogen and is now considered as an important cause of lower respiratory tract infection ,particularly in adults with chronic obstructive pulmonary disease. Aim of the study - To evaluate the significance of Moraxella catarrhalis as a pathogen in causing lower respiratory tract infections, to assess the risk factors and to determine the antibiotic susceptibility pattern of Moraxella catarrhalis. Materials and Methods This cross sectional study was conducted at the Institute of Microbiology over a period of 6 months at Madras Medical            College, Chennai. A total of 620 sputum samples were collected and processed from patients with suspected to be suffering from lower respiratory tract infection. The sputum samples were  subjected to Gram staining, bacterial culture and antimicrobial susceptibility testing of the isolates. Moraxella catarrhalis was identified based on the cultural characteristics and identified with the relevant biochemical reactions. The antimicrobial                 susceptibility testing of Moraxella catarrhalis was performed by Kirby Bauer Disc Diffusion method. Result Among 620 samples, the isolation rate of Moraxella catarrhalis was 9.35percentage and was more commonly seen in the age group of 50 and 50 years. Rate of isolation of Moraxella catarrhalis was higher in males(62.06percentage) than in females(37.93percentage).95.24 percentage of the isolates were susceptible to amoxicillin clavulanic acid and 17.24percentage sensitive to ampicillin only. Conclusion Isolation of Moraxella catarrhalis in the sputum sample from patients above 50 years of age , in the absence of other well established pathogen should not be disregarded, as they can cause lower respiratory tract infection in these individuals.

 


Full Text:

PDF

References


Jawetz E,Melnick JL,Adelberg EA eds. The Neisseria .Review of Medical Microbiology, 25th edition Lange Med Publications .Los Altos ,Calif

Berk SL.,From Micrococcus to Moraxella:The reemergence of B.catarrhalis ,Arch Intern Med 1990;150:2254-7.

Hager, H., A. Verghese, S. Alvarez, and S. L. Berk. 1987. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1140-1149.

Verduin, M., C. Hol, A. Fleer, Hansvandijk, and Alexvanbelkum. 2002. Moraxella catarrhalis: from emerging to established pathogen. Clin. Microbiol. Review. 15:125-144

Catin BW.Branhamella catarrhalis :an organism gaining respect as a pathogen. Clin Microbiol Rev.1990 ;3:293-320.

Murphy TF ,Parameshwaran GI.Moraxella catarrhalis ,A Human Respiratory Tract Pathogen. Clinical Infectious Disease.2009 ;49:124-31.

Bailey and Scott’s Diagnostic Microbiology ,12th edition .St.Louis, Misssouri , Mosby,2007.

Timothy F .Murphy .Branhamella catarrhalis :Epidemiology ,surface antigenic structure and immune response. Microbiological reviews,1996;60:267-279.

Prevalence of Moraxella catarrhalis infections of the lower respiratory tract in elderly patients.2005;3 :39-44.

Barreiro, B., L.Esteban, E. Prats, E. Verdaguer, J.Dorca, and F.Manresa.1992. Branhamella catarrhalis respiratory infections. Eur. Respir. J.5:675–679

Collazos, J., J. de Miguel, and R. Ayarza. 1992. Moraxella catarrhalisbacteremic pneumonia in adults: two cases and review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 11:237–24

DiGiovanni, C., T. V. Riley, G. F. Hoyne, R. Yeo, and P. Cooksey.1987. Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia. Epidemiol. Infect. 99:445-453.

Hager, H., A. Verghese, S. Alvarez, and S. L. Berk. 1987.Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1140–1149.

Gillian M Wood, Barbara C Johnson, Joseph G. McCormack. Moraxella catarrhalis: Pathogenic significance in respiratory tract infections treated by community practitioners. Clinical infectious diseases, 1996; 22:632-6

Anita K.B., Faseela T.S, Yashvanth K Rai, Chaithra S. Malli, Srikara Mallya Moraxella Catarrhalis: An Often Overlooked Pathogen of the Respiratory TractJournal of Clinical and Diagnostic Research. 2011 June, Vol5(3): 495-497

Anton F Ehrhardt, Rene Russo. Clinical resistance encountered in the respiratory surveillance programme (RESP) study: A review of implications for the treatment of community acquired respiratory tractinfections. The American Journal of Medicine. 17 Dec 2001;111(9A):31S.

Manninen R, Huovinen P, Nissinen A. The Finnish Study Group for Antimicrobial Resistance. Increasing antimicrobial resistance in Streptococcus pneumoniae, Hemophilus influenzae and Moraxella catarrhalis in Finland. Journal of Antimicrobial Chemotherapy. 1997;40:387-392

H. V. Prashanth , R. M. Dominic Saldanha *, Shalini Shenoy Moraxella catarrhalis - A Rediscovered PathogenInt J Biol Med Res. 2011; 2(4): 979- 981

Thornsberry C, Ogilvie P, Kahn J, Mauriz Y. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season. Diagn Microbiol Infect Dis. 1997;29:249–257. [PubMed]

B.V.Ramana and Abhijit Chaudhury Antibiotic sensitivity pattern of Moraxella catarrhalis at a tertiary care hospital. Int. J. of Pharm. & Life Sci.2012;3(7):1805-1806.

Koneman’s colour atlas and Textbook of Diagnostic Microbiology.6th edition.phases of diagnostic 22. cycle.pg:16-17.

Bailey and Scott’s Textbook of Diagnostic Microbiology, 12th edition –pg 451


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University